Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system

American Journal of Cardiology

Volumn 81, Issue 4, 1998, Pages 407-411

  Gordon, Bruce R ^a,b   Kelsey, Sheryl F ^a   Dau, Peter C ^a   Gotto Jr , Antonio M ^a   Graham, Kevin ^a   Illingworth, D Roger ^a   Isaacsohn, Jonathan ^a   Jones, Peter H ^a   Leitman, Susan F ^a   Saal, Stuart D ^a   Stein, Evan A ^a   Stern, Thomas N ^a   Troendle, August ^a   Zwiener, Robert J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b ROGOSIN INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

APHERESIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BLOOD COMPONENT REMOVAL; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DEXTRAN SULFATE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0032520169     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00947-8     Document Type: Article

References (14)

1. 1. Illingworth DR. How effective is drug therapy in heterozygous familial hypercholesterolemia? Am J Cardiol 1993;72:54D-58D.
2. 2. Gordon BR, Stein E, Jones P, Illingworth DR. Indications for low-density lipoprotein apheresis. Am J Cardiol 1994;74:1109-1113.
3. 3. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-622.
4. 4. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 1987;68:19-25.
5. 5. Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet 1981;2: 1005-1007.
6. 6. Schuff-Werner P, Armstrong VW, Eisenhauer TH, Thiery J, Seidel D. Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP). Contrib Infus Ther 1988;23:118-126.
7. 7. Gordon BR, Kelsey SF, Bilheimer DW, Brown DC, Dau PC, Gotto AM, Jr, Illingworth H, Leitman SF, Prihoda JS, Stein EA, Stern TN, Zavoral JH, Zwiener RJ. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol 1992;70:1010-1016.
8. 8. Yokoyama S, Yamamoto A, Hayashi R, Satani M. LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion. Jpn Circ J 1987;51:1116-1122.
9. 9. Borberg H, Gaczkowski A, Hombach V, Oette K, Stoffel W. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis. Prog Clin Biol Res 1988;255:317-326.
10. 10. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation 1997;95:76-82.
11. 11. Schuff-Werner P, Gohlke H, Bartmann U, Baggio G, Corti MC, Dinsenbacher A, Eisenhauer T, Grutzmacher P, Keller C, Kettner U, Kleophas W, Koster W, Olbricht CJ, Richter WO, Seidel D, and the HELP-Study Group. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Eur J Clin Invest 1994;24:724-732.
12. 12. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T, Yasugi T, Yamamoto A, Goto Y. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 1992;95:1-13.
13. 13. Thompson GR, Maher VMG, Mathews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, de Feyter P, Henderson A. The familial hypercholesterolaemia regression study: a randomised trial of low-density-lipoprotein apheresis. Lancet 1995;345:811-816.
14. 14. Kroon AA, Aengevaeren WRM, van der Werf T, Uijen GJH, Reiber JHC, Bruschke AVG, Stalenhoef AFH. LDL-apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93:1826-1835.